ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Short Interest UpdateZolmax • 28 days ago
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA Get Free Report) was the recipient of a significant growth in short interest in the month of March. As of March 15th, there was short interest...
Share to Feed
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the Company or IPA) (NASDAQ: IPA), InterSystems, a creative data technology provider dedicated to helping customers solve their most critical scalability...
Immunoprecise Antibodies partners with InterSystems to integrate Vector Search of IRIS data platform with BioStrand's LENSai for AI-driven healthcare solutions. Revolutionize drug discovery with...
Immunoprecise Antibodies Ltd. (IPA) has released an update. Immunoprecise Antibodies Ltd. (IPA) has allied with InterSystems to advance AI-driven h...
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the Company or IPA) (NASDAQ: IPA), an artificial intelligence-driven biotherapeutic research and technology company, today announced that it has acquired the LSA...
Benchmark reaffirmed their speculative buy rating on shares of ImmunoPrecise Antibodies (NASDAQ:IPA Free Report) in a report published on Friday morning, Benzinga reports. The firm currently...
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA Get Free Report) was the recipient of a significant drop in short interest during the month of February. As of February 29th, there was short...
Related Stocks: NAS:IPA...
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the Company or IPA) (NASDAQ: IPA), an artificial intelligence-driven biotherapeutic research and technology company, today reported financial results for its...
VICTORIA, BC / ACCESSWIRE / March 8, 2024 / Anyone familiar with the intricacies of life science knows how truly complicated DNA is; without a full understanding of the language of DNA, scientists...